Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

Podrobná bibliografie
Hlavní autoři:	Parikh, S, Obuku, E, Walker, SA, Semeere, A, Auerbach, B, Hakim, J, Mayanja-Kizza, H, Mugyenyi, P, Salata, R, Kityo, C
Médium:	Journal article
Jazyk:	English
Vydáno:	Public Library of Science 2013

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial.
Autor: Sujal M Parikh, a další
Vydáno: (2013-01-01)

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.
Autor: Kiwuwa-Muyingo, S, a další
Vydáno: (2012)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
Autor: Walker, A, a další
Vydáno: (2012)

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.
Autor: Jaganath, D, a další
Vydáno: (2014)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
Autor: Lara, A, a další
Vydáno: (2012)

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
Autor: Muyingo, S, a další
Vydáno: (2008)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
Autor: Antonieta Medina Lara, a další
Vydáno: (2012-01-01)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
Autor: Walker, A, a další
Vydáno: (2010)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
Autor: Gomo, Z, a další
Vydáno: (2014)

Prevalence and factors associated with hypertension among people living with HIV/AIDS on antiretroviral therapy in Uganda
Autor: Gloria Lubega, a další
Vydáno: (2021-02-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
Autor: Kityo, C, a další
Vydáno: (2014)

Provision of antiretroviral therapy in a rural setting – The Nile treatment centre experience, Uganda
Autor: Obuku Anthony, a další
Vydáno: (2006-12-01)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
Autor: Mugyenyi, P, a další
Vydáno: (2010)

Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda
Autor: Andreas Kuznik, a další
Vydáno: (2012-08-01)

Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART
Autor: William Worodria, a další
Vydáno: (2011-01-01)

DART and laboratory monitoring of HIV treatment Reply
Autor: Walker, A, a další
Vydáno: (2010)

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
Autor: Richard Makurumidze, a další
Vydáno: (2020-01-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
Autor: Cissy Kityo, a další
Vydáno: (2014-01-01)

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
Autor: Ssali, F, a další
Vydáno: (2006)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
Autor: Sempa Joseph, a další
Vydáno: (2012-09-01)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
Autor: Odere Mathew, a další
Vydáno: (2009-07-01)

Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda
Autor: Vasan Ashwin, a další
Vydáno: (2009-08-01)

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study
Autor: Inzaule, S, a další
Vydáno: (2016)

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.
Autor: Steven J Reynolds, a další
Vydáno: (2010-04-01)

Hypertension and associated risk factors in individuals infected with HIV on antiretroviral therapy at an urban HIV clinic in Uganda
Autor: Aggrey S Semeere, MMed MAS, a další
Vydáno: (2014-05-01)

Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.
Autor: Steven Baveewo, a další
Vydáno: (2011-01-01)

Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial
Autor: Post, F, a další
Vydáno: (2018)

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
Autor: Reid, A, a další
Vydáno: (2008)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
Autor: Seth C Inzaule, a další
Vydáno: (2016-01-01)

The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study
Autor: Ochola B, a další
Vydáno: (2022-05-01)

Immediate start of antiretroviral, why not?
Autor: Elaine Monteiro Matsuda, a další

Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
Autor: Richard Makurumidze, a další
Vydáno: (2020-01-01)

First‐line antiretroviral therapy durability in a 10‐year cohort of naïve adults started on treatment in Uganda
Autor: Barbara Castelnuovo, a další
Vydáno: (2016-01-01)

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
Autor: Barbara Castelnuovo, a další
Vydáno: (2015-01-01)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
Autor: Seth C Inzaule, a další
Vydáno: (2017-01-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
Autor: Paton, N, a další
Vydáno: (2014)

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
Autor: Johnston C, a další
Vydáno: (2009-06-01)

A 10-year retrospective study of lung cancer in Uganda
Autor: Naghib Bogere, a další
Vydáno: (2022-02-01)

Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda
Autor: Irene Nakatudde, a další
Vydáno: (2024-04-01)

Uptake of community antiretroviral group delivery models for persons living with HIV in Arua district, Uganda: A parallel convergent mixed methods study.
Autor: Wani Muzeyi, a další
Vydáno: (2023-01-01)

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

Podobné jednotky

Podobné jednotky